New blood test could spot kidney transplant rejection early
NCT ID NCT06026592
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 24 times
Summary
This study looks at a new way to monitor kidney transplant health by measuring kidney-specific DNA in the blood. Researchers will test 30 adults with end-stage kidney failure before and after their transplant surgery. The goal is to tell the difference between DNA from the patient's own failing kidneys and DNA from the new donated kidney, which could help detect rejection earlier.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Pitié-Salpétriêre Hospital
RECRUITINGParis, Île-de-France Region, 75013, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.